In a new study, researchers found that smoking high-potency marijuana concentrates boosts blood levels of THC more than twice as much as smoking conventional weed, but it doesn’t necessarily boost impairment.
The study is the first to assess the acute impact of cannabis among real-world users of legal market products.
It could inform everything from roadside sobriety tests to decisions about personal recreational or medicinal use.
But the study also raises concerns that using concentrates could unnecessarily put people at greater long-term risk of side-effects.
The research was conducted by the University of Colorado Boulder scientists.
While 33 states have legalized medicinal marijuana use, and 11 have legalized recreational use, both uses remain illegal at the federal level.
Researchers are also prohibited from handling or administering marijuana. Some previous studies have used strains supplied by the government, but those strains contain far less THC than real-world products.
In order to study what people really use, the utilize two white Dodge Sprinter vans, also known as the “cannavans,” as mobile laboratories.
They drive the vans to the residences of study subjects who use cannabis they purchase on their own inside their homes and then walk out for tests.
The team assessed 121 regular cannabis users. Half typically used concentrates (oils and waxes that include the active ingredients without the leaves and stems).
The other half typically used flowers from the plant. Flower users purchased a product containing either 16% or 24% [tetrahydrocannabinol (THC)], the main psychoactive ingredient in marijuana.
Concentrate users were assigned to a product containing either 70% or 90% THC.
On test day, researchers drew the subjects’ blood, measured their mood and intoxication level and assessed their cognitive function and balance at three time points: before, directly after and one hour after they used.
Those who used concentrates had much higher THC levels at all three points, with levels spiking to 1,016 micrograms per milliliter in the few minutes after use, while flower users spiked at 455 micrograms per milliliter.
(Previous studies have shown that THC levels hover around 160 to 380 micrograms per milliliter after marijuana use).
Regardless of what type or potency of cannabis participants used, their self-reports of intoxication, or “feeling high,” were remarkably similar, as were their measures of balance and cognitive impairment.
The study also found that, among all users, balance was about 11% worse after using cannabis, and memory was compromised. But within about an hour, that impairment faded.
The researchers think that regular users of concentrates likely develop tolerance over time.
There may be genetic or biological differences that make some people metabolize THC more quickly.
And it may be that once compounds in marijuana, called cannabinoids, fill receptors in the brain that spark intoxication, additional cannabinoids have little impact.
The authors caution that the study examined regular users who have learned to meter their use based on the desired effect, and does not apply to inexperienced users.
Those users should still be extremely cautious with concentrates. Ultimately, the researchers hope to learn what, if any, long-term health risks concentrates truly pose.
The lead author of the study is Cinnamon Bidwell, an assistant professor in the Institute of Cognitive Science.
The study is published in JAMA Psychiatry.
Copyright © 2020 Knowridge Science Report. All rights reserved.
